Truepill
Truepill is a digital health platform providing B2B solutions, including a Virtual Pharmacy, patient services, and nationwide prescription fulfillment.
Secondary Market Price
How Truepill Measures Up
To help you manage your Truepill equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Truepill's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Truepill Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Truepill's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Truepill develops a digital health platform focused on business-to-business pharmacy services. The company's core offerings include a Virtual Pharmacy digital experience, patient services designed to improve medication adherence and engagement, and URAC-accredited prescription fulfillment across all 50 states. These solutions allow healthcare partners to build and expand their own consumer-centric care programs. Founded in 2016 and headquartered in Hayward, California, Truepill has raised $255.4 million in total funding, with its last round being a Series D for $142 million in November 2021.
The company is currently undergoing a significant structural change. In 2024, Truepill announced it would begin operating as FuzeRx, the pharmacy services division of its new parent company, Fuze Health. According to the company, the transition builds on Truepill's existing services and expertise. In a public statement, the company affirmed that while its name is changing, its core dedication to serving patients and partners would remain the same. This rebranding followed an earlier announcement that Truepill was joining the Fuze Health organization.
- Oak HC/FT
- Optum Ventures
- TI Platform Management
- Sound Ventures
- Y Combinator
- Co-Founder, Umar Afridi
- Co-Founder, Sid Viswanathan
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Truepill worth joining?
Deciding whether to join any startup, including Truepill, requires careful consideration of the company's trajectory, culture, and your potential role. A key part of this decision is understanding the value of your equity offer, which tools like Prospect can help you model and understand.
What should I do with my Truepill stock?
Managing your startup stock involves creating a strategy for when to exercise options and when to sell shares to optimize your financial outcome and minimize taxes. Platforms like Prospect use predictive models and your financial data to build customized exercise and sale strategies for your private company equity.
Can you sell Truepill stock?
Selling stock in a private company like Truepill is often possible through secondary markets or company-organized tender offers, though it is more complex than selling public stock. Tools designed for startup employees can help you navigate these opportunities and decide which shares are most tax-optimal to sell.
How can I find the value of my Truepill stock?
The value of private company stock is typically determined by its most recent 409A valuation, the price set in a funding round, or secondary market transactions. To get a forward-looking estimate, platforms like Prospect use machine learning models trained on proprietary data to forecast the future value of your shares.
What is Truepill's equity worth?
A private company's valuation is typically established during its most recent funding round, which sets the price per share and overall worth. This valuation can change rapidly, and specialized tools can help you model potential future outcomes for your equity based on various market signals.
What is Truepill's stock ticker symbol?
Since Truepill is a private company, it is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell Truepill stock?
As a private company, Truepill stock is not available on public markets, and buying shares is typically limited to accredited investors or employees. Selling is generally possible through secondary markets or tender offers, but it is an illiquid asset with transfer restrictions.
What is the criteria to buy or invest in Truepill stock?
Investing in a private company like Truepill is typically restricted to employees receiving equity compensation or accredited investors participating in organized funding rounds. Opportunities to buy shares on secondary markets may also exist, but they are often limited and subject to company approval.
